<DOC>
	<DOCNO>NCT02187588</DOCNO>
	<brief_summary>Study determine kinetic analgesic effect 500 mg 1000 mg Eschscholtzia Californica per o placebo patient undergoing dental surgery observation period 6 hour . In secondary analysis , kinetic analgesic effect comparison Eschscholtzia californica 500 mg , 1000 mg Ibuprofen 200 mg</brief_summary>
	<brief_title>Study Assess Kinetic Analgesic Effect Tolerability Eschscholtzia Californica Versus Ibuprofen Placebo Treatment Pain After Surgery Third Molar</brief_title>
	<detailed_description />
	<mesh_term>Analgesics</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Male female 18 61 year old Patient undergo third molar removal lower jaw local troncular anesthesia ( articaine + adrenaline ) Type inclusion molar : Molar submucosa : Type II Molar partially impact bone : Type III Patient suffer least moderate severe pain surgical removal impact third molar , define 4 point verbal rating scale Patient 's informed consent accordance French legislation Patient affiliate Social Security System Pregnant nurse female female childbearing potential use medically approve method contraception like oral contraception intrauterine contraceptive device Patient pathology induce chronic pain Patient take drug analgesic property 24 hour previous administration study drug Patient concomitant administration NonSteroid AntiInflammatory Drug ( ) ( NSAIDs ) analgesic agent Patients treat antibiotic different require dental surgery administration start 48 hour prior tooth removal Patient significant perioperative complication judge investigator Patient anticoagulants concomitant treatment ( include heparin ) Patient severe hepatic renal insufficiency judge regard clinically relevant investigator know clinically significant disease may induce risk patient participate trial Patient mental disturbance Patient non control diabetes Patient acute infection Patient respiratory insufficiency , asthma Patient unable comply protocol Patient take part clinical trial past month already participate another trial Patient deprive freedom judicial administrative decision Adults guardianship Persons hospitalize medical social establishment Patients emergency situation Patient know suspected hypersensitivity trial medication , Ibuprofen , Paracetamol , anesthetic use ( articaine , adrenaline ) , preventive antibiotic treatment ( penicillin , macrolides ) Post study exclusion period : patient able participate trial period two week end trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>